BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 36988772)

  • 1. Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11.
    Wang C; Liu H; Xu S; Deng Y; Xu B; Yang T; Liu W
    Cell Mol Neurobiol; 2023 Aug; 43(6):2627-2642. PubMed ID: 36988772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma.
    Wang HH; Fan SQ; Zhan YT; Peng SP; Wang WY
    Int J Biol Macromol; 2024 Jan; 254(Pt 3):127976. PubMed ID: 37951442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
    Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
    He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
    J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo.
    Chen H; Cao L; Han K; Zhang H; Cui J; Ma X; Zhao S; Zhao C; Yin S; Fan L; Hu H
    Food Chem Toxicol; 2022 Aug; 166():113255. PubMed ID: 35772596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis.
    Zhang W; Li Q; Zhang Y; Wang Z; Yuan S; Zhang X; Zhao M; Zhuang W; Li B
    Apoptosis; 2024 Apr; 29(3-4):412-423. PubMed ID: 38001343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrate enhances erastin-induced ferroptosis of lung cancer cells via modulating the ATF3/SLC7A11 pathway.
    Bi R; Hu R; Jiang L; Wen B; Jiang Z; Liu H; Mei J
    Environ Toxicol; 2024 Feb; 39(2):529-538. PubMed ID: 37341073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X
    Song X; Zhu S; Chen P; Hou W; Wen Q; Liu J; Xie Y; Liu J; Klionsky DJ; Kroemer G; Lotze MT; Zeh HJ; Kang R; Tang D
    Curr Biol; 2018 Aug; 28(15):2388-2399.e5. PubMed ID: 30057310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P; Zhang Y; Zhuang L; Gan B
    Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection.
    Banerjee S; Sarkar R; Mukherjee A; Mitra S; Gope A; Chawla-Sarkar M
    Virus Res; 2024 Jan; 339():199261. PubMed ID: 37923170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma.
    Wang Z; Wang Y; Shen N; Liu Y; Xu X; Zhu R; Jiang H; Wu X; Wei Y; Tang J
    Cancer Lett; 2024 Mar; 584():216619. PubMed ID: 38211651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma.
    Yu H; Zhu K; Wang M; Jiang X
    Clin Transl Sci; 2023 Oct; 16(10):1957-1971. PubMed ID: 37503932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer.
    Saini KK; Chaturvedi P; Sinha A; Singh MP; Khan MA; Verma A; Nengroo MA; Satrusal SR; Meena S; Singh A; Srivastava S; Sarkar J; Datta D
    Redox Biol; 2023 Sep; 65():102833. PubMed ID: 37536085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification.
    Ye Y; Chen A; Li L; Liang Q; Wang S; Dong Q; Fu M; Lan Z; Li Y; Liu X; Ou JS; Lu L; Yan J
    Kidney Int; 2022 Dec; 102(6):1259-1275. PubMed ID: 36063875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
    Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
    Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis.
    Wang Z; Ouyang L; Liu N; Li T; Yan B; Mao C; Xiao D; Gan B; Liu S; Tao Y
    Oncogene; 2023 Sep; 42(36):2688-2700. PubMed ID: 37537342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.